DNA Adduct Formation and Removal in N-Acetoxy-2-Acetylaminofluorene-Exposed Cultured Cells and in Organs from Rats Fed 2-Acetylaminofluorene

  • Miriam C. Poirier
  • Stuart H. Yuspa
  • B’Ann True
  • Brian A. Laishes
Part of the Basic Life Sciences book series


The development of carcinogen DNA-adduct antibodies has made possible a new approach to investigate carcinogen-DNA interactions (1). To quantitate adducts of a particular carcinogen, highly-avid rabbit antibodies have been employed to allow detection by radioimmunoassay (RIA) of one adduct in 10 5DNA bases (1). The studies described here employed the antiserum anti-guanosin-(8-yl)-acetylaminofluorene (anti-G-8-AAF) elicited against the nucleoside-adduct coupled covalently to bovine serum albumin and injected into rabbits (2). The antiserum is specific for the acetylated and deacetylated C-8 adducts of 2-acetylaminofluorene (2-AAF) with DNA (dG-8-AAF and dG-8-AF) (see Figure 1). It does not cross-react with the minor adduct, 3-deoxyguanison(N2-yl)-acetylaminofluorene (dG-N2-AAF) (see Figure 1), the carcinogen alone, or DNA (2,3). Since the C-8 adducts comprise the major proportion (80 to 90%) of adducts formed upon interaction of 2-AAF, or its activated derivative N-acetoxy-2-acetylaminofluorene (N-Ac-AAF) with DNA in vivo (3,4,5), the anti-G-8-AAF was considered appropriate for initial studies. The antibody has been utilized to distinguish between the acetylated and deacetylated C-8 adducts of 2-AM in DNA, and to quantitate the proportions of each in DNA extracted from either cultured cells exposed to N-Ac-AAF or from livers and kidneys of male rats fed 2-AAF.


High Pressure Liquid Chromatography Adduct Level Normal Human Fibroblast Cesium Chloride Retinyl Acetate 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Poirier, M.C. 1981. Antibodies to carcinogen-DNA adducts. J. Natl. Cancer Inst. 67: 515–519.PubMedGoogle Scholar
  2. 2.
    Poirier, M.C., S.H. Yuspa, I.B. Weinstein, and S. Blobstein. 1977. Detection of carcinogen-DNA adducts by radioimmunoassay. Nature 270: 186–188.PubMedCrossRefGoogle Scholar
  3. 3.
    Poirier, M.C., M.A. Dubin, and S.H. Yuspa. 1979. Formation and removal of specific acetylaminofluorene-DNA adducts in mouse and human cells measured by radioimmunoassay. Cancer Res. 39: 1377–1381.PubMedGoogle Scholar
  4. 4.
    Kriek, E. 1972. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo. Cancer Res. 32: 2042–2048.PubMedGoogle Scholar
  5. 5.
    Beland, F.A., K.L. Dooley, and D.A. Casciano. 1979. Rapid isolation of carcinogen-bound DNA and RNA by hydroxyapatite chromatography. J. Chromatog. 174: 177–186.CrossRefGoogle Scholar
  6. 6.
    Poirier, M.C., G.M. Williams, and S.H. Yuspa. 1980. Effect of culture conditions, cell type, and species of origin on the distribution of acetylated and deacetylated deoxyguanosine C-8 adducts of N-acetoxy-2-acetylaminofluorene. Molec. Pharmacol. 18: 234–240.Google Scholar
  7. 7.
    Poirier, M.C. 1981. Measurement of the formation and removal of DNA adducts of N-acetoxy-2-acetylaminofluorene. In: DNA Repair: A Laboratory Manual of Research Procedures, Volume 1A. E.C. Friedberg and P.C. Hanawalt, eds. Marcel Dekker, Inc.: New York. pp. 143–153.Google Scholar
  8. 8.
    Laishes, B.A., and P.B. Rolfe. 1980. Quantitative assessment of liver colony formation and hepatocellular carcinoma incidence in rats receiving intravenous injections of isogeneic liver cells isolated during hepatocarcinogenesis. Cancer Res. 40: 4133–4143.PubMedGoogle Scholar
  9. 9.
    Poirier, M.C., and R.J. Connor. (in press). A radioimmunoassay for 2-acetylaminofluorene-DNA adducts. In: Immunochemical Techniques, Volume 2. H. Van Vunakis and J. Langone, eds. Academic Press: New York.Google Scholar
  10. 10.
    Kriek, E., and J.G. Westra. 1980. Structural identification of the pyrimidine derivatives formed from N-(deoxyguanosin-8-yl)-2-acetylaminofluorene in aqueous solution at alkaline pH. Carcinogenesis 1: 459–467.PubMedCrossRefGoogle Scholar
  11. 11.
    Yuspa, S.H., and C.C. Harris. 1974. Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp. Cell Res. 86: 95–105.PubMedCrossRefGoogle Scholar
  12. 12.
    Amacher, D.E., J.A. Elliott, and M.W. Lieberman. 1977. Differences in removal of acetylaminofluorene and pyrimidine dimers from the DNA of cultured mammalian cells. Proc. Natl. Acad. Sci. USA 74: 1553–1557.PubMedCrossRefGoogle Scholar
  13. 13.
    Amacher, D.E., and M.W. Lieberman. 1977. Removal of acetylaminofluorene from the DNA of control and repair-deficient human fibroblasts. Biochem. Biophys. Res. Comm. 74: 285–290.PubMedCrossRefGoogle Scholar
  14. 14.
    Sakai, S., C.E. Reinhold, P.J. Wirth, and S.S. Thorgiersson. 1978. Mechanism of in vitro mutagenic activation and covalent binding of N–hydroxy–2–acetylaminofluorene in isolated liver cell nuclei from rat and mouse. Cancer Res. 38–2058–2067.Google Scholar
  15. 15.
    Schut, H.A., P.J. Wirth, and S.S. Thorgiersson. 1978. Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the salmonella test system: The role of deacetylation by liver and kidney fractions from mouse and rat. Molec. Pharmacol. 14: 682–692.Google Scholar
  16. 16.
    Howard, P.C., F.A. Beland, and D.A. Casciano. 1981. Quantitation of N-hydroxy-2-acetylaminofluorene-mediated DNA adduct formation and the subsequent repair in primary rat hepatocyte cultures. J. Supra Struct. Cell. Biochem. Suppl. 5, Abstract 534, p. 197.Google Scholar
  17. 17.
    DeBaun, J.R., E.C. Miller, and J.A. Miller. 1970. N-hydroxy-2-acetylaminofluorene sulfotransferase: Its probable role in carcinogenesis and in protein (methion-S-yl) binding in rat liver. Cancer Res. 30: 577–595.PubMedGoogle Scholar
  18. 18.
    Cerutti, P.A. 1978. Repairable damage in DNA. In: DNA repair mechanisms: ICN-UCLA Symposia on Molecular and Cellular Biology, IA. P.C. Hanawalt, E.C. Friedberg, and C.F. Fox, eds. Academic Press: New York. pp. 1–14.Google Scholar
  19. 19.
    Levinson, J.W., B. Konze-Thomas, V.M. Maher, and J.J. McCormick. 1979. Evidence for a common rate-limiting step in the repair process of ultraviolet light and N-acetoxyacetylaminofluorene-induced damage in the DNA of human fibroblasts. Proc. Am. Assoc. Cancer Res. 20: 105.Google Scholar
  20. 20.
    King, C.M., and C.W. Olive. 1975. Comparative effects of strain, species, and sex on the acyltransferase-and sulfotransferase-catalyzed activations of N-hydroxy-N-2-fluorenylacetamide. Cancer Res. 35: 906–912.PubMedGoogle Scholar
  21. 21.
    Albert, R.E., F.J. Burns, L. Bilger, D. Gardner, and W. Troll. 1972. Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction. Cancer Res. 32: 2172–2177.PubMedGoogle Scholar
  22. 22.
    Stout, D.L., and F.F. Becker. 1978. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis. Cancer Res. 38: 2274–2278.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Miriam C. Poirier
    • 1
  • Stuart H. Yuspa
    • 1
  • B’Ann True
    • 2
  • Brian A. Laishes
    • 2
  1. 1.Laboratory of Experimental PathologyNational Cancer InstituteBethesdaUSA
  2. 2.McArdle Laboratory for Cancer ResearchUniversity of Wisconsin Medical SchoolMadisonUSA

Personalised recommendations